Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
65,166,587
-
Share change
-
+1,132,833
-
Total reported value
-
$3,052,735,802
-
Put/Call ratio
-
36%
-
Price per share
-
$46.87
-
Number of holders
-
195
-
Value change
-
+$63,378,491
-
Number of buys
-
101
-
Number of sells
-
95
Institutional Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q1 2015
As of 31 Mar 2015,
IMPAX LABORATORIES INC - COM (IPXL) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,166,587 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Invesco Ltd., ARAVT GLOBAL LLC, STATE STREET CORP, Pennant Capital Management, LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, and Slate Path Capital LP.
This page lists
195
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.